Written questions by Aquarone.

How many prescriptions for pancreatic enzyme replacement therapy were dispensed by Norfolk and Waveney (a) integrated care board and (b) clinical commissioning group in each year between 2019 and 2024.

The Prescription Cost Analysis (PCA) provided by the NHS Business Services Authority gives the total number of prescription items of each medicine dispensed in the community in England. The following data relates to prescriptions for products that fall within the definition as set out in Paragraph 010904, related to pancreatin, in the British National Formulary.The following table shows the total number of National Health Service prescription items that were dispensed in the Norfolk and Waveney Integrated Care Board, regardless of where prescribed, from January 2019 to November 2024YearNumber of prescription items201914,291202013,587202113,933202213,933202314,460202414,698Note: data for 2024 is from January to November.The Clinical Commissioning Group (CCG) relates to the prescribing organisation, so the following statistics are consistent with the English Prescribing datasets rather than the dispensing organisation shown in PCA.The following table shows the total number of NHS prescription items that were prescribed by cost centres linked to the Sub Integrated Care Board Location (SICBL), or prior to 2020 the CCG area of Norfolk and Waveney, from January 2019 to November 2024:YearNumber of prescription items201914,290202013,727202114,238202214,387202314,904202414,935Note: data for 2024 is from January to November.Historical data has been re-presented using the latest NHS organisation structure. These two tables are not directly comparable as the data available for integrated care boards relates to dispensing, whereas the data available at the SICBL or CCG level relates to items prescribed.

Pursuant to the Answer of 8 January 2025 to Question 21526 on Methylphenidate: Norfolk, how many prescriptions for methylphenidate were dispensed by Norfolk and Waveney (a) integrated care board and (b) clinical commissioning group in each year between 2019 and 2024.

The Prescription Cost Analysis (PCA) from the NHS Business Services Authority provides the total number of prescription items of each medicine dispensed in the community in England. The following table shows the total number of National Health Service prescription items for the chemical substance methylphenidate that were dispensed in the Norfolk and Waveney Integrated Care Board (ICB) area from January 2019 to October 2024, latest data available, regardless of where prescribed:Total prescription items dispensed in Norfolk and Waveney ICB201933,733202030,723202131,320202231,267202332,138202428,249Note: data for 2024 is from January to October. In addition, the following table shows the total number of NHS prescription items for the chemical substance methylphenidate that were prescribed by cost centres linked to the Sub ICB Location (SICBL), or prior to 2020, the Clinical Commissioning Group (CCG) area of Norfolk and Waveney, from January 2019 to October 2024:Total prescription items prescribed in Norfolk and Waveney SICBL201931,751202029,665202130,334202230,431202331,233202427,086Notes:data for 2024 is from January to October; andhistorical data has been re-presented using the latest NHS organisation structure.The CCG relates to the prescribing organisation, so the statistics are consistent with the English prescribing datasets rather than the dispensing organisation shown in PCA.

Pursuant to the Answer of 29 November 2024 to Question 16285 on Methylphenidate: Shortages, what estimate he has made of the number of prescriptions for methylphenidate (a) successfully and (b) uns

The Prescription Cost Analysis, produced by the NHS Business Services Authority (NHSBSA), provides the total number of prescription items of each medicine dispensed in the community in England.There were 28,249 National Health Service prescription items f...

Pursuant to the Answer of 24 October 2024 to Question 9576 on Methylphenidate: Shortages, what recent progress her Department has made on improving the supply of methylphenidate in (a) Norfolk and

We are continuing to work to resolve supply issues, where they remain, for methylphenidate prolonged-release tablets. We are engaging with all suppliers to assess the challenges faced and their actions to address them. We are also directing suppliers to s...

If he will support the implementation of the Optimal Care Pathway for pancreatic cancer.

We are committed to transforming the National Health Service so that we diagnose cancer earlier, treat it faster, and improve survival rates.On 12 September 2024 the National Cancer Audit Collaborating Centre published their State of the Nation Report on ...

Whether (a) pancreatic cancer and (b) other cancers with lower survival rates will have a focused section in the new cancer strategy.

The Government’s Health Mission sets the aim of building a National Health Service fit for the future and reducing the lives lost to the biggest killers, including cancer. As part of that work, and in response to Lord Darzi’s report, we have launched an e...

Whether his Department plans to review recent closures of GP surgeries.

The closure of a general practice (GP) surgery is an issue that is considered and decided upon by local commissioners, following an application from a GP provider. Practices close for a variety of reasons, including mergers or retirement, and so do not ne...

If he will make an assessment of the potential merits of establishing a fund to support GP services in (a) rural and (b) other remote areas.

General practitioners receive global sum funding for providing core services, comprising approximately 50 to 60% of practice income. The global sum is a capitated payment, calculated based on the size of a practice’s registered list of patients, and weigh...